A STRESSED mum has shared how she hypnotised herself into shedding nearly two stone, getting over her paralysing fear of the ...

Presented by AstraZeneca{beacon} Health Care Health Care   The Big Story CMS targets hospitals with site-neutral drug ruleThe ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence individuals' weight loss after taking GLP-1RAs such as semaglutide (sold under the brand names ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

When it comes to speaking to colleagues about your diagnosis, Carolyn asks patients to write down three different ways ...

The 61-year-old man received a new kidney from a deceased donor after being diagnosed with “nephrosclerosis-related end-stage kidney disease,” or chronic high blood pressure that causes hardening of ...

These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and why.

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

A woman who gained 10 stone due to a rare condition lost the weight in two years - by doing one exercise every day. Hannah Mai, 37, was diagnosed with Cushing's disease - a hormonal disorder caused by ...

In Some Ozempic Households, the Weight Loss Is Contagious Patients taking the drugs are finding their families are benefiting, too.

Some GLP-1 users report "Ozempic smell," a newfound attraction to sweet perfumes and scents, possibly linked to how the medications affect the brain regions controlling smell and taste.

More people are "microdosing" GLP-1 medications like Ozempic, Wegovy, and Mounjaro. Here's what to know and what to be cautious of, according to doctors.